Below is a comparison of today’s most prescribed GLP-1 medications, including Ozempic and Trulicity, both widely used for ...

Weight regain is common after stopping GLP-1s, as appetite increases and the body tries to return you to your previous weight ...

The OWN media mogul, who began taking a GLP-1 medication in 2023, told People she feels "more alive and more vibrant" than ...

The discovery of GLP-1 and its role in regulating blood glucose was a major scientific breakthrough in diabetes research, yet turning this peptide hormone into an effective medication was no easy task ...

Both Novo Nordisk’s and competitor Eli Lilly’s injectable GLP-1 drugs, Wegovy and Zepbound, have helped transform obesity ...

Obesity treatment is hurtling into a new era: once-a-week GLP-1 injections are edging toward the dramatic results of bariatric surgery, yet many of us remain tethered to the very habits that fuel ...

Stars including Oprah Winfrey and Serena Williams share stories about taking GLP-1 medications to manage their weight and ...

Sprout Health Serves as Case Study for Provider Model Structure, Program Costs, and FDA-vs-Compounded Disclosure Standards ...

Glucagon-like peptide-1 (GLP-1) agonists have transformed weight loss treatments. However, about half of the patients who take these drugs stop within a year because of unwanted side effects. 1,2 For ...

GLP-1 drugs are expanding beyond diabetes to potentially reduce heart disease and improve sleep quality. Market for GLP-1 drugs is set to grow from $70 billion in 2025 to $157 billion by 2030, led by ...